Capital Asset Advisory Services LLC Edwards Lifesciences Corp Transaction History

Capital Asset Advisory Services LLC

$2.01 Billion
Q3 2024

A detailed history of Capital Asset Advisory Services LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 3,623 shares of EW stock, worth $245,494. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,623

Previous 3,727 2.79%

Holding current value

$245,494

Previous $344,000 30.52%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$59.7 - $93.78 $6,208 - $9,753	-104 Reduced 2.79%	3,623 $239,000
Q2 2024 Jul 24, 2024	SELL	$84.3 - $94.31 $1,686 - $1,886	-20 Reduced 0.53%	3,727 $344,000
Q1 2024 Apr 16, 2024	BUY	$72.54 - $95.56 $797 - $1,051	11 Added 0.29%	3,747 $358,000
Q4 2023 Jan 09, 2024	BUY	$61.71 - $77.76 $3,949 - $4,976	64 Added 1.74%	3,736 $284,000
Q3 2023 Oct 18, 2023	SELL	$69.28 - $93.38 $1,732 - $2,334	-25 Reduced 0.68%	3,672 $254,000
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $1,953 - $2,263	-24 Reduced 0.64%	3,697 $348,000
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $25,174 - $28,648	-339 Reduced 8.35%	3,721 $307,000
Q4 2022 Mar 08, 2023	BUY	$68.3 - $87.44 $277,298 - $355,006	4,060 New	4,060 $302,000
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $439,506 - $651,739	5,081 New	5,081 $483,000
Q3 2020 Nov 18, 2020	SELL	$67.19 - $87.44 $703,479 - $915,496	-10,470 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $602,443 - $805,666	10,470 New	10,470 $803,000
Q1 2020 May 18, 2020	SELL	$52.41 - $81.0 $187,889 - $290,385	-3,585 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $249,157 - $285,262	3,475 Added 3159.09%	3,585 $829,000
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $243,780 - $279,106	-3,400 Reduced 96.87%	110 $836,000
Q3 2019 Oct 10, 2019	SELL	$61.55 - $75.43 $1,846 - $2,262	-30 Reduced 0.85%	3,510 $772,000
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $696 - $854	-15 Reduced 0.42%	3,540 $542,000
Q3 2018 Jan 31, 2019	SELL	$45.7 - $58.03 $2,285 - $2,901	-50 Reduced 1.39%	3,555 $619,000
Q2 2018 Jul 11, 2018	SELL	$42.45 - $51.3 $18,041 - $21,802	-425 Reduced 10.55%	3,605 $525,000
Q1 2018 May 16, 2018	SELL	$37.19 - $47.45 $1,301 - $1,660	-35 Reduced 0.86%	4,030 $562,000
Q4 2017 Jan 11, 2018	SELL	$33.79 - $39.39 $21,794 - $25,406	-645 Reduced 13.69%	4,065 $458,000
Q3 2017 Oct 30, 2017	BUY	$36.29 - $38.83 $170,925 - $182,889	4,710	4,710 $515,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.

Account

Capital Asset Advisory Services LLC Edwards Lifesciences Corp Transaction History